StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Reality of Business

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jul 30, 2021 10:48am

91 Views

Post# 33631895

RE:RE:Reality of Business

I agree.

RelevantStock wrote:

capebretongirl wrote: A good thing here is that we will now get closure of this deal on Aug 14 followed two days later by Q2 results - that tight time frame shold give us a nice boost.

Good thinking, happy to see that deal close and eager to have some news about how Aristotle is being used in avert.